Early research (Phase 1)Ended earlyNCT05561530
What this trial is testing
ALG-125755 to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics After Single Doses in Healthy Volunteers, and Single and Multiple Doses in CHB Subjects
Who this might be right for
Chronic Hepatitis B
Aligos Therapeutics 57